Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACORQ

Acorda Therapeutics (ACORQ) Stock Price, News & Analysis

Acorda Therapeutics logo

About Acorda Therapeutics Stock (NASDAQ:ACORQ)

Advanced Chart

Key Stats

Today's Range
$0.01
$0.01
50-Day Range
$0.01
$0.06
52-Week Range
$0.01
$18.00
Volume
N/A
Average Volume
67,585 shs
Market Capitalization
$12.42 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACORQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acorda Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ACORQ Stock News Headlines

Ex-PNP chief Acorda denies POGO involvement
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

Company Calendar

Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ACORQ
CIK
1008848
Employees
102
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$252.85 million
Net Margins
-227.75%
Pretax Margin
-263.21%

Debt

Sales & Book Value

Annual Sales
$117.63 million
Price / Cash Flow
N/A
Book Value
($127.17) per share
Price / Book
0.00

Miscellaneous

Free Float
1,210,000
Market Cap
$12.42 thousand
Optionable
N/A
Beta
1.67
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:ACORQ) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners